Skip to main content

Table 3 Bleeding events according to CYP2C9 and VKORC1 genotype.

From: Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction

CYP2C9 genotype

VKORC1 genotype

N (%)

Mean INR (95% C.I.)

Major/minor bleeding events N (%)

Occult bleeding events N (%)

Total bleeding events N (%)

*1/*1

C/C

33 (31.4)

2.65 (2.45–2.84)

2 (6.1)

4 (12.1)

6 (18.2)

 

C/T

28 (26.7)

2.79 (2.60–2.99)

3 (10.7)

5 (17.9)

8 (28.6)

 

T/T

12 (11.4)

2.71 (2.37–3.05)

2 (16.7)

-

2 (16.7)

*1/*2,*3

C/C

8 (7.6)

2.58 (2.19–2.96)

-

1 (12.5)

1 (12.5)

 

C/T

16 (15.2)

2.83 (2.55–3.10)

2 (12.5)

4 (25.0)

6 (37.5)

 

T/T

3 (2.9)

2.87 (2.49–3.25)

   

*2/*2,*3

C/C

2 (1.9)

2.30 (1.03–3.57)

   
 

C/T

2 (1.9)

2.15 (0.24–4.06)

   
 

T/T

1 (1.0)

3.50

   

Total

 

105 (100)

 

9

14

23